XML 52 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:      
Net income $ 348,074us-gaap_NetIncomeLoss $ 424,362us-gaap_NetIncomeLoss $ 750,269us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 52,686us-gaap_DepreciationDepletionAndAmortization 41,204us-gaap_DepreciationDepletionAndAmortization 36,940us-gaap_DepreciationDepletionAndAmortization
Non-cash compensation expense 307,238us-gaap_ShareBasedCompensation 198,399us-gaap_ShareBasedCompensation 94,157us-gaap_ShareBasedCompensation
Non-cash interest expense 18,052us-gaap_OtherNoncashExpense 23,061us-gaap_OtherNoncashExpense 22,925us-gaap_OtherNoncashExpense
Loss on Extinguishment of Debt 33,469us-gaap_GainsLossesOnExtinguishmentOfDebt 0us-gaap_GainsLossesOnExtinguishmentOfDebt 0us-gaap_GainsLossesOnExtinguishmentOfDebt
Other non-cash charges and expenses, net 30,003us-gaap_OtherNoncashIncomeExpense 23,690us-gaap_OtherNoncashIncomeExpense 34,049us-gaap_OtherNoncashIncomeExpense
Increase (Decrease) in Deferred Income Taxes (66,604)us-gaap_IncreaseDecreaseInDeferredIncomeTaxes 63,601us-gaap_IncreaseDecreaseInDeferredIncomeTaxes (340,156)us-gaap_IncreaseDecreaseInDeferredIncomeTaxes
Changes in assets and liabilites      
Increase in Sanofi, Bayer HealthCare, and trade accounts receivable (62,432)us-gaap_IncreaseDecreaseInAccountsReceivable (258,994)us-gaap_IncreaseDecreaseInAccountsReceivable (588,398)us-gaap_IncreaseDecreaseInAccountsReceivable
Increase in Inventories (60,900)us-gaap_IncreaseDecreaseInInventories (47,956)us-gaap_IncreaseDecreaseInInventories (28,932)us-gaap_IncreaseDecreaseInInventories
(Increase) decrease in prepaid expenses and other assets (37,767)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets 7,571us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (25,371)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Increase (decrease) in deferred revenue 19,102us-gaap_IncreaseDecreaseInDeferredRevenue (27,974)us-gaap_IncreaseDecreaseInDeferredRevenue (41,077)us-gaap_IncreaseDecreaseInDeferredRevenue
Increase in accounts payable, accrued expenses and other liabilities 162,236us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 136,684us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 10,979us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Total adjustments 395,083us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities 159,286us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities (824,884)us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Net cash provided by (used in) operating activities 743,157us-gaap_NetCashProvidedByUsedInOperatingActivities 583,648us-gaap_NetCashProvidedByUsedInOperatingActivities (74,615)us-gaap_NetCashProvidedByUsedInOperatingActivities
Cash flows from investing activities:      
Purchases of marketable securities (564,188)us-gaap_PaymentsToAcquireMarketableSecurities (577,278)us-gaap_PaymentsToAcquireMarketableSecurities (470,945)us-gaap_PaymentsToAcquireMarketableSecurities
Sales or maturities of marketable securities 476,417us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities 378,146us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities 439,209us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities
Capital expenditures (333,006)us-gaap_PaymentsToAcquireProductiveAssets (156,323)us-gaap_PaymentsToAcquireProductiveAssets (49,337)us-gaap_PaymentsToAcquireProductiveAssets
Net cash used in by investing activities (420,777)us-gaap_NetCashProvidedByUsedInInvestingActivities (355,455)us-gaap_NetCashProvidedByUsedInInvestingActivities (81,073)us-gaap_NetCashProvidedByUsedInInvestingActivities
Cash flows from financing activities:      
Payments in connection with facility and capital lease obligations (1,095)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations (2,024)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations (2,203)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations
Repayments of convertible senior debt (220,639)us-gaap_RepaymentsOfConvertibleDebt 0us-gaap_RepaymentsOfConvertibleDebt 0us-gaap_RepaymentsOfConvertibleDebt
Payments in connection with reduction of outstanding warrants (294,552)us-gaap_PaymentsForRepurchaseOfWarrants 0us-gaap_PaymentsForRepurchaseOfWarrants 0us-gaap_PaymentsForRepurchaseOfWarrants
Proceeds from issuance of Common Stock 126,045us-gaap_ProceedsFromIssuanceOfCommonStock 57,393us-gaap_ProceedsFromIssuanceOfCommonStock 63,549us-gaap_ProceedsFromIssuanceOfCommonStock
Payments in connection with Common Stock tendered for employee tax obligations (267,584)us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation (195,087)us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation (163,300)us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation
Excess tax benefit from stock-based compensation 448,556us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities 216,857us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities 4,308us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
Net cash (used in) provided by financing activities (209,269)us-gaap_NetCashProvidedByUsedInFinancingActivities 77,139us-gaap_NetCashProvidedByUsedInFinancingActivities (97,646)us-gaap_NetCashProvidedByUsedInFinancingActivities
Net increase (decrease) in cash and cash equivalents 113,111us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 305,332us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (253,334)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of period 535,608us-gaap_CashAndCashEquivalentsAtCarryingValue 230,276us-gaap_CashAndCashEquivalentsAtCarryingValue 483,610us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of period 648,719us-gaap_CashAndCashEquivalentsAtCarryingValue 535,608us-gaap_CashAndCashEquivalentsAtCarryingValue 230,276us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosure of cash flow information      
Cash paid for interest (net of amounts capitalized) 20,614us-gaap_InterestPaidNet 23,842us-gaap_InterestPaidNet 21,946us-gaap_InterestPaidNet
Cash paid for income taxes $ 59,847us-gaap_IncomeTaxesPaidNet $ 1,057us-gaap_IncomeTaxesPaidNet $ 0us-gaap_IncomeTaxesPaidNet